Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | FOXA1 |
| Upstream (Parents) |
|---|
| (<<) SPDEF → FOXA1 |
| (<<) L3MBTL4 → FOXA1 |
| Downstream (Children) |
|---|
| FOXA1 → TFAP2B (>>) |
| FOXA1 → ELF5 (>>) |
| FOXA1 → IRX1 (>>) |
| FOXA1 → EN1 (>>) |
| FOXA1 → ZIC1 (>>) |
| FOXA1 → FOXC1 (>>) |
| FOXA1 → SOX10 (>>) |
| FOXA1 → CDKN2A (>>) |
| FOXA1 → ANKRD30A (>>) |
| FOXA1 → SIX1 (>>) |
| FOXA1 → SOX2 (>>) |
| FOXA1 → TFCP2L1 (>>) |
| FOXA1 → EHF (>>) |
| FOXA1 → GATA3 (>>) |
| FOXA1 → SIX3 (>>) |
| FOXA1 → HOXC10 (>>) |
| FOXA1 → TRIM29 (>>) |
| FOXA1 → TP63 (>>) |
| FOXA1 → AR (>>) |
| FOXA1 → NFIA (>>) |
| FOXA1 → HOXB3 (>>) |
| FOXA1 → NFIB (>>) |
| FOXA1 → SIX2 (>>) |
| FOXA1 → FOXM1 (>>) |
| FOXA1 → NFIX (>>) |
| FOXA1 → CREB3L4 (>>) |
| FOXA1 → NR4A2 (>>) |
| FOXA1 → HOXB6 (>>) |
| FOXA1 → RUNX3 (>>) |
| FOXA1 → TAF4B (>>) |
| FOXA1 → MYC (>>) |
| FOXA1 → MSX2 (>>) |
| FOXA1 → TRPS1 (>>) |
| FOXA1 → XBP1 (>>) |
| FOXA1 → RORC (>>) |
| FOXA1 → TCF7L1 (>>) |
| FOXA1 → ASCL2 (>>) |
| FOXA1 → HOXB2 (>>) |
| FOXA1 → NFE2L3 (>>) |
| FOXA1 → ZNF91 (>>) |
| FOXA1 → PGR (>>) |
| FOXA1 → THRB (>>) |
| FOXA1 → MECOM (>>) |
| FOXA1 → PCGF2 (>>) |
| FOXA1 → CREB5 (>>) |
| FOXA1 → HOXC9 (>>) |
| FOXA1 → TRERF1 (>>) |
| FOXA1 → PLSCR1 (>>) |
| FOXA1 → PBX1 (>>) |
| FOXA1 → TSC22D3 (>>) |
| FOXA1 → RARA (>>) |
| FOXA1 → MEIS1 (>>) |
| FOXA1 → TCF19 (>>) |
| FOXA1 → GATA2 (>>) |
| FOXA1 → PPARA (>>) |
| FOXA1 → TCEAL1 (>>) |
| FOXA1 → ZNF92 (>>) |
| FOXA1 → SCML2 (>>) |
